Supplementary Table 1 from Randomized Phase II Study of Durvalumab with or Without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer

Eric Winquist, Sebastien J. Hotte, Kim Chi,Srikala Sridhar, Susan Ellard,Michael Ong, Nayyer Iqbal, Muhammad Salim,Urban Emmenegger, Joel R. Gingerich, Aly-Khan Lalani, Pierre Major,Christian Kollmannsberger,Steven Yip,Aaron Hansen, Daygen Finch, Christina Canil, James Hutchenreuther, Francisco Vera-Badillo,Martin Smoragiewicz,Michael Cabanero, Ming-Sound Tsao,Elie Ritch, Alexander W. Wyatt,Lesley Seymour

crossref（2025）

Cited 0|Views0

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined